The analysts of ROTH Capital Partners, LLC have rated Humanigen with a Buy rating. The price target was set to $25.00. At a current price of $ 12.29 there is upside potential of 103.42%. Bullish
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.